Top Key Companies for Targeted Sequencing and Resequencing Market: Agilent Technologies, Illumina, F. Hoffmann-La Roche, Thermo Fisher Scientific, DNASTAR, PacBio, Bio-Rad Laboratories, Integrated DNA Technologies, Perkin Elmer, RainDance Technologies, PierianDx, BGI, Genomatix GmbH, Macrogen, GATC Biotech Ag, Oxford Nanopore Technologies, QIAGEN.
Global Targeted Sequencing and Resequencing Market Research Report: 2025-2032 Outlook with Market Insights, Industry and Competitive Analysis Included. Remarkable growth trajectory projected.
Global Targeted Sequencing and Resequencing Market Overview And Scope:
The Global Targeted Sequencing and Resequencing Market Report 2025 provides comprehensive analysis of market development components, patterns, flows, and sizes. This research study of Targeted Sequencing and Resequencing utilized both primary and secondary data sources to calculate present and past market values to forecast potential market management for the forecast period between 2025 and 2032. It includes the study of a wide range of industry parameters, including government policies, market environments, competitive landscape, historical data, current market trends, technological innovations, upcoming technologies, and technological progress within related industries. Additionally, the report provides an in-depth analysis of the value chain and supply chain to demonstrate how value is added at every stage in the product lifecycle. The study incorporates market dynamics such as drivers, restraints/challenges, trends, and their impact on the market.
Global Targeted Sequencing and Resequencing Market Segmentation
By Type, Targeted Sequencing and Resequencing market has been segmented into:
DNA-based Targeted Sequencing
RNA-based Targeted Sequencing
By Application, Targeted Sequencing and Resequencing market has been segmented into:
Clinical Application
Plant and Animal Sciences
Drug Development
Others
Regional Analysis of Targeted Sequencing and Resequencing Market:
North America (U.S., Canada, Mexico)
Eastern Europe (Bulgaria, The Czech Republic, Hungary, Poland, Romania, Rest of Eastern Europe)
Western Europe (Germany, UK, France, Netherlands, Italy, Russia, Spain, Rest of Western Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Bahrain, Kuwait, Saudi Arabia, Qatar, UAE, Israel, South Africa)
Competitive Landscape of Targeted Sequencing and Resequencing Market:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The Targeted Sequencing and Resequencing market study focused on including all the primary level, secondary level and tertiary level competitors in the report.The data generated by conducting the primary and secondary research. The report covers detail analysis of driver, constraints and scope for new players entering the Targeted Sequencing and Resequencing market.
Top Key Companies Covered in Targeted Sequencing and Resequencing market are:
Agilent Technologies
Illumina
F. Hoffmann-La Roche
Thermo Fisher Scientific
DNASTAR
PacBio
Bio-Rad Laboratories
Integrated DNA Technologies
Perkin Elmer
RainDance Technologies
PierianDx
BGI
Genomatix GmbH
Macrogen
GATC Biotech Ag
Oxford Nanopore Technologies
QIAGEN
Key Questions answered in the Targeted Sequencing and Resequencing Market Report:
1. What is the expected Targeted Sequencing and Resequencing Market size during the forecast period, 2025-2032?
2. Which region is the largest market for the Targeted Sequencing and Resequencing Market?
3. What is the expected future scenario and the revenue generated by different regions and countries in the Targeted Sequencing and Resequencing Market, such as North America, Europe, AsiaPacific & Japan, China, U.K., South America, and Middle East and Africa?
4. What is the competitive strength of the key players in the Targeted Sequencing and Resequencing Market on the basis of the analysis of their recent developments, product offerings, and regional presence?
5. Where do the key Targeted Sequencing and Resequencing companies lie in their competitive benchmarking compared to the factors of market coverage and market potential?
6. How are the adoption scenario, related opportunities, and challenges impacting the Targeted Sequencing and Resequencing Markets?
7. How is the funding and investment landscape in the Targeted Sequencing and Resequencing Market?
8. Which are the leading consortiums and associations in the Targeted Sequencing and Resequencing Market, and what is their role in the market?
Chapter 1: Introduction
1.1 Research Objectives
1.2 Research Methodology
1.3 Research Process
1.4 Scope and Coverage
1.4.1 Market Definition
1.4.2 Key Questions Answered
1.5 Market Segmentation
Chapter 2:Executive Summary
Chapter 3:Growth Opportunities By Segment
3.1 By Type
3.2 By Application
Chapter 4: Market Landscape
4.1 Porter's Five Forces Analysis
4.1.1 Bargaining Power of Supplier
4.1.2 Threat of New Entrants
4.1.3 Threat of Substitutes
4.1.4 Competitive Rivalry
4.1.5 Bargaining Power Among Buyers
4.2 Industry Value Chain Analysis
4.3 Market Dynamics
4.3.1 Drivers
4.3.2 Restraints
4.3.3 Opportunities
4.5.4 Challenges
4.4 Pestle Analysis
4.5 Technological Roadmap
4.6 Regulatory Landscape
4.7 SWOT Analysis
4.8 Price Trend Analysis
4.9 Patent Analysis
4.10 Analysis of the Impact of Covid-19
4.10.1 Impact on the Overall Market
4.10.2 Impact on the Supply Chain
4.10.3 Impact on the Key Manufacturers
4.10.4 Impact on the Pricing
Chapter 5: Targeted Sequencing and Resequencing Market by Type
5.1 Targeted Sequencing and Resequencing Market Overview Snapshot and Growth Engine
5.2 Targeted Sequencing and Resequencing Market Overview
5.3 DNA-based Targeted Sequencing
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size (2017-2032F)
5.3.3 Key Market Trends, Growth Factors and Opportunities
5.3.4 DNA-based Targeted Sequencing: Geographic Segmentation
5.4 RNA-based Targeted Sequencing
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size (2017-2032F)
5.4.3 Key Market Trends, Growth Factors and Opportunities
5.4.4 RNA-based Targeted Sequencing: Geographic Segmentation
Chapter 6: Targeted Sequencing and Resequencing Market by Application
6.1 Targeted Sequencing and Resequencing Market Overview Snapshot and Growth Engine
6.2 Targeted Sequencing and Resequencing Market Overview
6.3 Clinical Application
6.3.1 Introduction and Market Overview
6.3.2 Historic and Forecasted Market Size (2017-2032F)
6.3.3 Key Market Trends, Growth Factors and Opportunities
6.3.4 Clinical Application: Geographic Segmentation
6.4 Plant and Animal Sciences
6.4.1 Introduction and Market Overview
6.4.2 Historic and Forecasted Market Size (2017-2032F)
6.4.3 Key Market Trends, Growth Factors and Opportunities
6.4.4 Plant and Animal Sciences: Geographic Segmentation
6.5 Drug Development
6.5.1 Introduction and Market Overview
6.5.2 Historic and Forecasted Market Size (2017-2032F)
6.5.3 Key Market Trends, Growth Factors and Opportunities
6.5.4 Drug Development: Geographic Segmentation
6.6 Others
6.6.1 Introduction and Market Overview
6.6.2 Historic and Forecasted Market Size (2017-2032F)
6.6.3 Key Market Trends, Growth Factors and Opportunities
6.6.4 Others: Geographic Segmentation
Chapter 7: Company Profiles and Competitive Analysis
7.1 Competitive Landscape
7.1.1 Competitive Positioning
7.1.2 Targeted Sequencing and Resequencing Sales and Market Share By Players
7.1.3 Industry BCG Matrix
7.1.4 Heat Map Analysis
7.1.5 Targeted Sequencing and Resequencing Industry Concentration Ratio (CR5 and HHI)
7.1.6 Top 5 Targeted Sequencing and Resequencing Players Market Share
7.1.7 Mergers and Acquisitions
7.1.8 Business Strategies By Top Players
7.2 AGILENT TECHNOLOGIES
7.2.1 Company Overview
7.2.2 Key Executives
7.2.3 Company Snapshot
7.2.4 Operating Business Segments
7.2.5 Product Portfolio
7.2.6 Business Performance
7.2.7 Key Strategic Moves and Recent Developments
7.2.8 SWOT Analysis
7.3 ILLUMINA
7.4 F. HOFFMANN-LA ROCHE
7.5 THERMO FISHER SCIENTIFIC
7.6 DNASTAR
7.7 PACBIO
7.8 BIO-RAD LABORATORIES
7.9 INTEGRATED DNA TECHNOLOGIES
7.10 PERKIN ELMER
7.11 RAINDANCE TECHNOLOGIES
7.12 PIERIANDX
7.13 BGI
7.14 GENOMATIX GMBH
7.15 MACROGEN
7.16 GATC BIOTECH AG
7.17 OXFORD NANOPORE TECHNOLOGIES
7.18 QIAGEN
Chapter 8: Global Targeted Sequencing and Resequencing Market Analysis, Insights and Forecast, 2017-2032
8.1 Market Overview
8.2 Historic and Forecasted Market Size By Type
8.2.1 DNA-based Targeted Sequencing
8.2.2 RNA-based Targeted Sequencing
8.3 Historic and Forecasted Market Size By Application
8.3.1 Clinical Application
8.3.2 Plant and Animal Sciences
8.3.3 Drug Development
8.3.4 Others
Chapter 9: North America Targeted Sequencing and Resequencing Market Analysis, Insights and Forecast, 2017-2032
9.1 Key Market Trends, Growth Factors and Opportunities
9.2 Impact of Covid-19
9.3 Key Players
9.4 Key Market Trends, Growth Factors and Opportunities
9.4 Historic and Forecasted Market Size By Type
9.4.1 DNA-based Targeted Sequencing
9.4.2 RNA-based Targeted Sequencing
9.5 Historic and Forecasted Market Size By Application
9.5.1 Clinical Application
9.5.2 Plant and Animal Sciences
9.5.3 Drug Development
9.5.4 Others
9.6 Historic and Forecast Market Size by Country
9.6.1 US
9.6.2 Canada
9.6.3 Mexico
Chapter 10: Eastern Europe Targeted Sequencing and Resequencing Market Analysis, Insights and Forecast, 2017-2032
10.1 Key Market Trends, Growth Factors and Opportunities
10.2 Impact of Covid-19
10.3 Key Players
10.4 Key Market Trends, Growth Factors and Opportunities
10.4 Historic and Forecasted Market Size By Type
10.4.1 DNA-based Targeted Sequencing
10.4.2 RNA-based Targeted Sequencing
10.5 Historic and Forecasted Market Size By Application
10.5.1 Clinical Application
10.5.2 Plant and Animal Sciences
10.5.3 Drug Development
10.5.4 Others
10.6 Historic and Forecast Market Size by Country
10.6.1 Bulgaria
10.6.2 The Czech Republic
10.6.3 Hungary
10.6.4 Poland
10.6.5 Romania
10.6.6 Rest of Eastern Europe
Chapter 11: Western Europe Targeted Sequencing and Resequencing Market Analysis, Insights and Forecast, 2017-2032
11.1 Key Market Trends, Growth Factors and Opportunities
11.2 Impact of Covid-19
11.3 Key Players
11.4 Key Market Trends, Growth Factors and Opportunities
11.4 Historic and Forecasted Market Size By Type
11.4.1 DNA-based Targeted Sequencing
11.4.2 RNA-based Targeted Sequencing
11.5 Historic and Forecasted Market Size By Application
11.5.1 Clinical Application
11.5.2 Plant and Animal Sciences
11.5.3 Drug Development
11.5.4 Others
11.6 Historic and Forecast Market Size by Country
11.6.1 Germany
11.6.2 UK
11.6.3 France
11.6.4 Netherlands
11.6.5 Italy
11.6.6 Russia
11.6.7 Spain
11.6.8 Rest of Western Europe
Chapter 12: Asia Pacific Targeted Sequencing and Resequencing Market Analysis, Insights and Forecast, 2017-2032
12.1 Key Market Trends, Growth Factors and Opportunities
12.2 Impact of Covid-19
12.3 Key Players
12.4 Key Market Trends, Growth Factors and Opportunities
12.4 Historic and Forecasted Market Size By Type
12.4.1 DNA-based Targeted Sequencing
12.4.2 RNA-based Targeted Sequencing
12.5 Historic and Forecasted Market Size By Application
12.5.1 Clinical Application
12.5.2 Plant and Animal Sciences
12.5.3 Drug Development
12.5.4 Others
12.6 Historic and Forecast Market Size by Country
12.6.1 China
12.6.2 India
12.6.3 Japan
12.6.4 South Korea
12.6.5 Malaysia
12.6.6 Thailand
12.6.7 Vietnam
12.6.8 The Philippines
12.6.9 Australia
12.6.10 New Zealand
12.6.11 Rest of APAC
Chapter 13: Middle East & Africa Targeted Sequencing and Resequencing Market Analysis, Insights and Forecast, 2017-2032
13.1 Key Market Trends, Growth Factors and Opportunities
13.2 Impact of Covid-19
13.3 Key Players
13.4 Key Market Trends, Growth Factors and Opportunities
13.4 Historic and Forecasted Market Size By Type
13.4.1 DNA-based Targeted Sequencing
13.4.2 RNA-based Targeted Sequencing
13.5 Historic and Forecasted Market Size By Application
13.5.1 Clinical Application
13.5.2 Plant and Animal Sciences
13.5.3 Drug Development
13.5.4 Others
13.6 Historic and Forecast Market Size by Country
13.6.1 Turkey
13.6.2 Bahrain
13.6.3 Kuwait
13.6.4 Saudi Arabia
13.6.5 Qatar
13.6.6 UAE
13.6.7 Israel
13.6.8 South Africa
Chapter 14: South America Targeted Sequencing and Resequencing Market Analysis, Insights and Forecast, 2017-2032
14.1 Key Market Trends, Growth Factors and Opportunities
14.2 Impact of Covid-19
14.3 Key Players
14.4 Key Market Trends, Growth Factors and Opportunities
14.4 Historic and Forecasted Market Size By Type
14.4.1 DNA-based Targeted Sequencing
14.4.2 RNA-based Targeted Sequencing
14.5 Historic and Forecasted Market Size By Application
14.5.1 Clinical Application
14.5.2 Plant and Animal Sciences
14.5.3 Drug Development
14.5.4 Others
14.6 Historic and Forecast Market Size by Country
14.6.1 Brazil
14.6.2 Argentina
14.6.3 Rest of SA
Chapter 15 Investment Analysis
Chapter 16 Analyst Viewpoint and Conclusion
Targeted Sequencing and Resequencing Scope:
Report Data
|
Targeted Sequencing and Resequencing Market
|
Targeted Sequencing and Resequencing Market Size in 2025
|
USD XX million
|
Targeted Sequencing and Resequencing CAGR 2025 - 2032
|
XX%
|
Targeted Sequencing and Resequencing Base Year
|
2024
|
Targeted Sequencing and Resequencing Forecast Data
|
2025 - 2032
|
Segments Covered
|
By Type, By Application, And by Regions
|
Regional Scope
|
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
|
Key Companies Profiled
|
Agilent Technologies, Illumina, F. Hoffmann-La Roche, Thermo Fisher Scientific, DNASTAR, PacBio, Bio-Rad Laboratories, Integrated DNA Technologies, Perkin Elmer, RainDance Technologies, PierianDx, BGI, Genomatix GmbH, Macrogen, GATC Biotech Ag, Oxford Nanopore Technologies, QIAGEN.
|
Key Segments
|
By Type
DNA-based Targeted Sequencing RNA-based Targeted Sequencing
By Applications
Clinical Application Plant and Animal Sciences Drug Development Others
|